Report
GlobalData Department
EUR 108.55 For Business Accounts Only

Petoro AS - Strategic SWOT Analysis Review

Petoro AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Petoro AS (Petoro) is an oil and gas asset management company. Petoro manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets to ensure maximum value and reach the highest possible income to the State from SDFI. The company has three major responsibilities assigned by the state government, namely, to manage the government’s holdings in the joint venture, to monitor Equinor’s marketing of the petroleum which is produced from the state’s direct financial interest in upstream assets, and to manage the government’s financial investments. The company is owned by the government of Norway. Petoro is headquartered in Stavanger, Norway.

Petoro AS Key Recent Developments

Nov 29,2021: Equinor and partners submit plan for the Oseberg field in the North Sea
Nov 23,2021: Drilling permit for well 6306/9-1 in production licence 886
Nov 23,2021: NPD: Drilling permit for well 6306/9-1 in production licence 886
Nov 10,2021: Equinor, Aker Solutions sign FPSO FEED contract for Wisting field
Nov 10,2021: Equinor: Awarding major Wisting assignments to Norwegian industry

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
Provider
GlobalData Plc
GlobalData Plc

​GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.

Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.

Analysts
GlobalData Department

Other Reports from GlobalData Plc

ResearchPool Subscriptions

Get the most out of your insights

Get in touch